The Rise of AI-Biotech: Why Hong Kong is the Next Breeding Ground for HealthTech Startups
August 12, 2026
Less than 15% of drug candidates make it from the laboratory to the market. Every stage between those two points asks your company to solve a different business challenge. One phase may call for funding, and the next could depend on clinical partners. Another may revolve around protecting your intellectual…